Investment Q&A

Q: NDM (Northern Dynasty Minerals) has recently seen price increases. After reviewing previous Q/A, I notice NDM has a lot of controversy. Have those problems of the past been resolved enough to justify the market's current price? Do you think it's buyable, or still too speculative?

Q:

BCE is trending down, ex-dividend. If YOU would cut the dividend, would you wait for next earning release in May, or sooner? What would be the probability the stock stays flat, instead of up or down when/if the dividend is cut?

Is Rogers a better bet at the moment or just a hold (I just sold it for tax loss) ?
I’m sticking with my Telus for now.
Thanks. Have a good week.

Q: I own BN with no intention of selling, but I find the dividends of the other Brookfield's interesting for my RRSP account with the potential of some capital growth as well. I know this type of question has been asked in the past, but not since the market downturn. Would you see a benefit of owning any of the others along with BN, and if so, which ones, and what would your total percentage of Brookfield holdings be. Thanks!

Q: Looking for a stable US stock with some growth/dividend. Please make suggestions

Q: hello 5i:
IF one wanted to buy one Consumer Discretionary stock and nothing the obvious size difference, could you comment on current fundamental/valuation differences, growth rates, balance sheet advantages, etc

thanks
Paul L

Q: Hello,

Why the drop today? Good time to start a position, or do you see more downside?

Thanks.

Q: I am working on increasing my sector representation in Healthcare. I will shortly have filled a full position in ISRG, adding in this downturn. I have traded around UNH, and am planning to take it from a 1/2 to full position. I have 1/4 position in ILMN and do not think I should be topping it up; I perceive it to be risky. I need 2 more companies, or may need to take one or both of IRSG/UNH to more than a full position.

This provides me a surgical/instrumentation company and a service/product supplier. For diversity in the Healthcare space can you rank your preferred buys (with entry points) I'd appreciate 2 recommendations on the pharmaseuticals side and 2 on the biotech side, or as you may see that fits better.

While I am open US companies I do have a concern that the Trump administration will bring the DOGE and Executive Order train wrecks to health care. I would appreciate your views on this potential action and howe it may impact investment choice in the field.

Thanks as always,

Dave

Q: Could Trump force the Canadian banks & insurance companies close their operations in the U.s. and sell the proceeds to their U.S. competitors?

Q: hello
it was Eric N top pick around 12-18 months ago
it was gone down from in the 90s to the 60s
with the drilling enthusiasm By the US , how come it has come down so much
what will be the factors making this stock turn around?
or should one stay with the pipelines for a safer investment?
thanks
Michael

Q: Can , you give me your take on CIA ,I am down 28% should I buy more, what seems to be the problem is the crazy politics.

Thank you
James Allore.

Q: Sorry for the long list, but that's my IT holdings and I need help to get to a more disciplined IT portfolio. About equal weight, except for SHOP which was owned and is currently on watchlist. Question 1- please advise a limited high conviction IT - does 5 sound about right? It would really help me if you could explain why these are chosen as I want to understand my investments. Question 2 - which ones to sell outright so that can redeploy funds? Any to hold for potential high growth potential?

Q: Hi Guys,

With ALL the uncertainty in North America, what would be your top 10 stocks for 3 to 5 year hold?

thanks

Jim

Q: As they have moved to U.S. is there now a withholding tax on their dividends?

Q: This company was a recent top pick on BNN, the last question on it seems to be many years ago. The share price has come off pretty dramatically recently. Can I please have your latest thoughts on their prospects and current valuation?

Q: Friday’s meeting between Mark Carney and the Premiers promises to lead to increased spending and capital to build infrastructure related to natural resources, alternative energy and technology. There seems to be a vibe consistent with Brookfield visions and foci. Carney may in fact be a catalyst to moving the Canadian economy out of the current malaise. Skepticism is warranted but are there any specific stocks that we should consider in light of what could develop rather quickly?

Q: I've held Lockheed Martin (LMT) for 11 years and enjoyed a solid return of nearly 14% per annum, largely driven by the success of the global F-35 program, which has been a cornerstone of LMT’s revenue and earnings growth. However, with today’s announcement that Boeing has won the Next Generation Air Dominance (NGAD) fighter jet contract—potentially worth over $20 billion initially and hundreds of billions over its lifetime—I’m concerned about the impact on LMT’s future growth and outlook. The loss of this high-profile sixth-generation fighter program to a competitor could signal a shift in market dynamics, especially given LMT’s historical dominance in advanced fighter jets. How do you assess the implications of this decision for LMT’s long-term growth trajectory, particularly in terms of its Aeronautics division and overall market position? I’m considering selling my position due to this turn of events, though it would mean realizing a significant capital gain in my taxable account, and I’d likely reinvest in another aerospace and defense industrial, such as Northrop Grumman or even Boeing itself. Could you share your analysis of how this contract loss might affect LMT’s valuation and growth prospects, and offer your thoughts on whether selling now and reallocating makes sense for an investor like me seeking both growth and stability?I'm a retired investor and do benefit from the dividend growth of LMT. Please factor into your overall comments. Thank you!

Q: I am considering investing in this company as it appears to be one of the only companies in this sector that is growing even though it is not a big. Can you please give me your analysis on its prospects and position and advise if it is worthwhile long term investment,

Q: Morning Troops. This is more of a hopeful question than anything. It is now almost a certainty that we will be spending more on defence regardless of who wins the election. If it actually comes to pass that our country decides to ease up on defence procurement from the US and spend more at home, how are companies like CAE positioned to profit from this and do you see it happening? Cheers.

Q: On August 16 last year, High Arctic split the company into two entities (HOH and new HWO). For each share of HWO held, shareholders received one-quarter of a common share of HOH and one-quarter of a common share of post-Arrangement HWO.

I haven’t been able to determine how to apportion my original cost between the two. My RBC statement shows that they (RBC) attributed 100% of my existing cost to the new HWO but they attributed an addition $0.50 per share to HOH.

They have a generic footnote that says (re: HOH) “Part of or all of the Book Cost on this security position is unknown resulting in the use of market value… Please contact us to update the statement records.”

I would like to do that, but I don’t know what the amount should be.

On their website, HWO says,
“High Arctic Energy Services Inc. has determined that the fair market value [HOH] shares ... on August 12, 2024 is $1.755 per High Arctic Overseas Holdings Corp. common share”.

Does that mean I should (or could) use $1.755 as my cost per share of HOH, and deduct in from my cost per share of HWO? Other suggestion?

Thanks,

Q: QSI I have been following this stock for the past few weeks and it has been increasing daily.
Can you provide your usual service in providing a review of this business.
Thanks in advance